Urophilia has been conceptualized by sexual arousal caused by urine which is an under-researched area, globally. There is a paucity of data regarding its prevalence and association with other psychiatric conditions. Individuals with urophilia derive sexual gratification from smell, sight and even consumption of urine of the sexual partner.
Objectives
We report a case of urophilia with obsessive-compulsive disorder in an adult male, which the first reported case of urophilia in Bangladesh.
Method
After getting the informed consent, details of history were obtained, routine physical examination and mental status of the patient was performed.
Results
We report a case of 35 years old Bangladeshi male presented with urophilia and obsessive-compulsive disorder.
Conclusion
This is the first reported case of urophilia in a sexually conservative country, Bangladesh.
{"title":"Urophilia associated with obsessive-compulsive disorder in a Bangladeshi male: A rare case report","authors":"S.M. Yasir Arafat , Sujita Kumar Kar , Sanjida Tanjin Khan","doi":"10.1016/j.npbr.2020.04.003","DOIUrl":"10.1016/j.npbr.2020.04.003","url":null,"abstract":"<div><h3>Background</h3><p>Urophilia has been conceptualized by sexual arousal caused by urine which is an under-researched area, globally. There is a paucity of data regarding its prevalence and association with other psychiatric conditions. Individuals with urophilia derive sexual gratification from smell, sight and even consumption of urine of the sexual partner.</p></div><div><h3>Objectives</h3><p>We report a case of urophilia with obsessive-compulsive disorder in an adult male, which the first reported case of urophilia in Bangladesh.</p></div><div><h3>Method</h3><p>After getting the informed consent, details of history were obtained, routine physical examination and mental status of the patient was performed.</p></div><div><h3>Results</h3><p>We report a case of 35 years old Bangladeshi male presented with urophilia and obsessive-compulsive disorder.</p></div><div><h3>Conclusion</h3><p>This is the first reported case of urophilia in a sexually conservative country, Bangladesh.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 96-97"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48974435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.npbr.2020.02.001
C. Bustamante, Carlos Ancatén, Cristian Gutiérrez-Rojas, R. Pascual
{"title":"Maternal exercise during pregnancy prevents neurocognitive impairments in the juvenile offspring induced by prenatal stress","authors":"C. Bustamante, Carlos Ancatén, Cristian Gutiérrez-Rojas, R. Pascual","doi":"10.1016/j.npbr.2020.02.001","DOIUrl":"https://doi.org/10.1016/j.npbr.2020.02.001","url":null,"abstract":"","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77454460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01DOI: 10.1016/j.npbr.2020.02.004
A. Congio, Maisa Norcia, M. Urbano, W. Verri, S. Nunes
{"title":"Association of clinical features and biomarkers with treatment-resistant depression","authors":"A. Congio, Maisa Norcia, M. Urbano, W. Verri, S. Nunes","doi":"10.1016/j.npbr.2020.02.004","DOIUrl":"https://doi.org/10.1016/j.npbr.2020.02.004","url":null,"abstract":"","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86920908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-02-13DOI: 10.1016/j.npbr.2020.02.003
Robabeh Farzaneh , Ayyoub Malek , Farhad Mirzaei , Shahrokh Amiri , Firooz Salehpour , Ali Meshkini , Zahra Musavi , Sara Farhang , Saeed Dastgiri , Ali Farzane , Fatemeh Ghanbari
Background
A range of psychiatric disorders are associated with brain tumors. The aim of this study was to assess the frequency of psychiatric disorders in adults with primary brain tumors before and after surgery.
Methods
The study was conducted on 120 adult patients diagnosed with primary brain tumors (age ≥18 years). Patients with recent diagnosis (less than 6 months) who were hospitalized in Imam Reza Hospital of Tabriz between December 2016 and November 2017 were included. The diagnostic interview was performed based on DSM-IV criteria using a semi-structured interview with SCID-I before and one month after surgery. The frequency of psychiatric disorders in patients was then compared pre- and post-operation.
Results
Pre-surgical studies revealed that 26.66 % of patients with primary brain tumors had symptoms of psychiatric disorders. The most prevalent disorders found in patients were depressive disorders (13.07 %), adjustment disorder (9/15 %) and anxiety disorders (5.88 %).
Post-surgical evaluations indicated that the frequency of psychiatric disorders was reduced to 22.5 %. However, there was no significant difference between pre- and post-surgical outcomes. Among patients with psychiatric disorders, the most common location of brain tumors was frontal lobe and the most common pathology was meningioma. Further analysis also revealed that tumor location and pathology was not associated with the incidence and type of psychiatric disorders.
Conclusion
In adults with primary brain tumors, the most common psychiatric disorder was depressive disorder.
{"title":"Evaluation of comorbid psychiatric disorders in patients with primary brain tumors before and after surgery","authors":"Robabeh Farzaneh , Ayyoub Malek , Farhad Mirzaei , Shahrokh Amiri , Firooz Salehpour , Ali Meshkini , Zahra Musavi , Sara Farhang , Saeed Dastgiri , Ali Farzane , Fatemeh Ghanbari","doi":"10.1016/j.npbr.2020.02.003","DOIUrl":"10.1016/j.npbr.2020.02.003","url":null,"abstract":"<div><h3>Background</h3><p>A range of psychiatric disorders are associated with brain tumors. The aim of this study was to assess the frequency of psychiatric disorders in adults with primary brain tumors before and after surgery.</p></div><div><h3>Methods</h3><p>The study was conducted on 120 adult patients diagnosed with primary brain tumors (age ≥18 years). Patients with recent diagnosis (less than 6 months) who were hospitalized in Imam Reza Hospital of Tabriz between December 2016 and November 2017 were included. The diagnostic interview was performed based on DSM-IV criteria using a semi-structured interview with SCID-I before and one month after surgery. The frequency of psychiatric disorders in patients was then compared pre- and post-operation.</p></div><div><h3>Results</h3><p>Pre-surgical studies revealed that 26.66 % of patients with primary brain tumors had symptoms of psychiatric disorders. The most prevalent disorders found in patients were depressive disorders (13.07 %), adjustment disorder (9/15 %) and anxiety disorders (5.88 %).</p><p>Post-surgical evaluations indicated that the frequency of psychiatric disorders was reduced to 22.5 %. However, there was no significant difference between pre- and post-surgical outcomes. Among patients with psychiatric disorders, the most common location of brain tumors was frontal lobe and the most common pathology was meningioma. Further analysis also revealed that tumor location and pathology was not associated with the incidence and type of psychiatric disorders.</p></div><div><h3>Conclusion</h3><p>In adults with primary brain tumors, the most common psychiatric disorder was depressive disorder.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 8-13"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.02.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43920280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-02-27DOI: 10.1016/j.npbr.2020.02.008
David L Dunner, Ryan M Fugate, Christina M Demopulos
Background
Treatment of depression with monoamine oxidase inhibitors (MAOIs) is complicated by the risk of drug interactions and possible serotonin syndrome if antidepressants with monoamine enhancement are used concomitantly. Esketamine nasal spray is a recently FDA approved antidepressant for individuals with treatment resistant depression and is to be used adjunctively with antidepressant pharmacotherapy. We report a patient who was successfully and safely treated with esketamine nasal spray while being treated with tranylcypromine.
Methods
This patient was treated in our Center and data regarding blood pressure and side effect were reviewed from her clinical record.
Results
Baseline depression and anxiety ratings, including HAM A, QIDS, HAMD and MADRS, were in the range of moderate range of anxiety and depression. Baseline GAD 7 was only slightly elevated. At the end of the 4 week acute treatment phase (treatments of esketamine nasal spray twice weekly at doses ranging from 28 to 56 mg), all of her mood and anxiety ratings were in the normal range. Blood pressure usually increases during treatment with esketamine nasal spray, and increases during treatment were within the normal range and there was no evidence of hypertension. Esketamine nasal spray was well tolerated and there was no evidence of a serotonin syndrome.
Limitations
This is a single case report, but we review the literature of treatment of patients taking MAOIs with ketamine and with intravenous esketamine.
Conclusions
Esketamine nasal spray appears to be a safe treatment even if administered to a patient being treated with tranylcypromine, an MAOI.
{"title":"Safety and efficacy of esketamine nasal spray in a depressed patient who was being treated with tranylcypromine: A case report","authors":"David L Dunner, Ryan M Fugate, Christina M Demopulos","doi":"10.1016/j.npbr.2020.02.008","DOIUrl":"10.1016/j.npbr.2020.02.008","url":null,"abstract":"<div><h3>Background</h3><p>Treatment of depression with monoamine oxidase inhibitors (MAOIs) is complicated by the risk of drug interactions and possible serotonin syndrome if antidepressants with monoamine enhancement are used concomitantly. Esketamine nasal spray is a recently FDA approved antidepressant for individuals with treatment resistant depression and is to be used adjunctively with antidepressant pharmacotherapy. We report a patient who was successfully and safely treated with esketamine nasal spray while being treated with tranylcypromine.</p></div><div><h3>Methods</h3><p>This patient was treated in our Center and data regarding blood pressure and side effect were reviewed from her clinical record.</p></div><div><h3>Results</h3><p>Baseline depression and anxiety ratings, including HAM A, QIDS, HAMD and MADRS, were in the range of moderate range of anxiety and depression. Baseline GAD 7 was only slightly elevated. At the end of the 4 week acute treatment phase (treatments of esketamine nasal spray twice weekly at doses ranging from 28 to 56 mg), all of her mood and anxiety ratings were in the normal range. Blood pressure usually increases during treatment with esketamine nasal spray, and increases during treatment were within the normal range and there was no evidence of hypertension. Esketamine nasal spray was well tolerated and there was no evidence of a serotonin syndrome.</p></div><div><h3>Limitations</h3><p>This is a single case report, but we review the literature of treatment of patients taking MAOIs with ketamine and with intravenous esketamine.</p></div><div><h3>Conclusions</h3><p>Esketamine nasal spray appears to be a safe treatment even if administered to a patient being treated with tranylcypromine, an MAOI.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 30-31"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.02.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42512839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-04-18DOI: 10.1016/j.npbr.2020.03.004
S.M. Yasir Arafat , Bithika Mali , Hasina Akter
Background
Epidemiology of suicide has been found as an under-attended research focus in Bangladesh.
Objectives
It was aimed to see demography, methods and precipitating events of suicidal attempts that were published in Bangla online news portals.
Methods
We searched and scrutinized published news contents of four Bangla online news portals reporting the suicidal news between 01 November 2018 and 31 October 2019. A total of 199 articles were collected and subsequently analyzed.
Results
The mean age of suicide attempters reported in the news portals was 26.86 (±13.60) years, ranging from 9 to 75 years. More than 60 % of the reported cases were less than 30 years of age, 53 % were female, 32.16 % were students, and 52.3 % were unmarried. Hanging was found as the commonest method (60 %) and affair related issues (17.59 %), marital discords (13.57 %), familial discords (10.55 %), were found as the mentionable precipitating events. About 83 % of the suicides happened at the home of the person, multiple persons were involved in the suicidal acts in about 8% of the respondents, 91 % were completed suicides, and 4% suicide reports were associated with homicides.
Conclusion
The study showed adults less than thirty years, females, and students are exhibiting more suicidal behaviors. Hanging was the most commonly used method and the majority of the precipitating events were within the family.
{"title":"Characteristics of suicidal attempts in Bangla online news portals","authors":"S.M. Yasir Arafat , Bithika Mali , Hasina Akter","doi":"10.1016/j.npbr.2020.03.004","DOIUrl":"10.1016/j.npbr.2020.03.004","url":null,"abstract":"<div><h3>Background</h3><p>Epidemiology of suicide has been found as an under-attended research focus in Bangladesh.</p></div><div><h3>Objectives</h3><p>It was aimed to see demography, methods and precipitating events of suicidal attempts that were published in Bangla online news portals.</p></div><div><h3>Methods</h3><p>We searched and scrutinized published news contents of four Bangla online news portals reporting the suicidal news between 01 November 2018 and 31 October 2019. A total of 199 articles were collected and subsequently analyzed.</p></div><div><h3>Results</h3><p>The mean age of suicide attempters reported in the news portals was 26.86 (±13.60) years, ranging from 9 to 75 years. More than 60 % of the reported cases were less than 30 years of age, 53 % were female, 32.16 % were students, and 52.3 % were unmarried. Hanging was found as the commonest method (60 %) and affair related issues (17.59 %), marital discords (13.57 %), familial discords (10.55 %), were found as the mentionable precipitating events. About 83 % of the suicides happened at the home of the person, multiple persons were involved in the suicidal acts in about 8% of the respondents, 91 % were completed suicides, and 4% suicide reports were associated with homicides.</p></div><div><h3>Conclusion</h3><p>The study showed adults less than thirty years, females, and students are exhibiting more suicidal behaviors. Hanging was the most commonly used method and the majority of the precipitating events were within the family.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 83-85"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.03.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72827947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-03-30DOI: 10.1016/j.npbr.2020.03.002
Paula L. Jacobsen , Eileen M. Thorley , Christopher Curran
Background
Sexual dysfunction negatively impacts quality of life and relationship satisfaction in patients with major depressive disorder (MDD). This study’s objective was to understand real-world experiences with sexual dysfunction in patients with MDD.
Methods
This survey study included 483 participants (≥18 years old) from the PatientsLikeMe® network who reported an MDD diagnosis. Sexual dysfunction (self-attributed and as evaluated by the Changes in Sexual Functioning Questionnaire [CSFQ-14]), relationship satisfaction, depression severity, and medication adherence were assessed.
Results
Of the patients currently taking antidepressants (N = 405), sexual dysfunction was reported in approximately half (self-attributed, 52 % and per CSFQ-14, 56 %). Forty-eight percent of these patients indicated they would continue medication until sexual side effects abated. Fewer than half of patients with self-attributed sexual dysfunction, reported for at least one antidepressant, had spoken with their doctor about sexual side effects; of these, about one-third were switched to another antidepressant. Sexual dysfunction was associated with depression severity, diminished relationship satisfaction, and lower self-esteem in patients currently taking antidepressants.
Limitations
This is a convenience sample; data are based on self-report without independent verification of the diagnoses. The cross-sectional design also limits conclusions about causality and directionality. The generalizability of the findings is limited, as the patient sample was predominantly female, white, college educated, and moderately to severely depressed.
Conclusions
New strategies for managing sexual dysfunction in patients with MDD who are taking antidepressants are critically needed to provide these patients with the best chance for successful treatment outcomes.
{"title":"Real-world patient experience with sexual dysfunction and antidepressant use in patients with self-reported depression: A cross-sectional survey study","authors":"Paula L. Jacobsen , Eileen M. Thorley , Christopher Curran","doi":"10.1016/j.npbr.2020.03.002","DOIUrl":"10.1016/j.npbr.2020.03.002","url":null,"abstract":"<div><h3>Background</h3><p>Sexual dysfunction negatively impacts quality of life and relationship satisfaction in patients with major depressive disorder (MDD). This study’s objective was to understand real-world experiences with sexual dysfunction in patients with MDD.</p></div><div><h3>Methods</h3><p>This survey study included 483 participants (≥18 years old) from the PatientsLikeMe® network who reported an MDD diagnosis. Sexual dysfunction (self-attributed and as evaluated by the Changes in Sexual Functioning Questionnaire [CSFQ-14]), relationship satisfaction, depression severity, and medication adherence were assessed.</p></div><div><h3>Results</h3><p>Of the patients currently taking antidepressants (N = 405), sexual dysfunction was reported in approximately half (self-attributed, 52 % and per CSFQ-14, 56 %). Forty-eight percent of these patients indicated they would continue medication until sexual side effects abated. Fewer than half of patients with self-attributed sexual dysfunction, reported for at least one antidepressant, had spoken with their doctor about sexual side effects; of these, about one-third were switched to another antidepressant. Sexual dysfunction was associated with depression severity, diminished relationship satisfaction, and lower self-esteem in patients currently taking antidepressants.</p></div><div><h3>Limitations</h3><p>This is a convenience sample; data are based on self-report without independent verification of the diagnoses. The cross-sectional design also limits conclusions about causality and directionality. The generalizability of the findings is limited, as the patient sample was predominantly female, white, college educated, and moderately to severely depressed.</p></div><div><h3>Conclusions</h3><p>New strategies for managing sexual dysfunction in patients with MDD who are taking antidepressants are critically needed to provide these patients with the best chance for successful treatment outcomes.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 57-64"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.03.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87389879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-03-17DOI: 10.1016/j.npbr.2020.03.001
Arezu Marefat, Leila Sadeghi
Objectives
Ions are key regulators of the morphogenesis, dendritogenesis and development of neurons therefore drugs that perturb ion homeostasis are associated with high risk of mental retardation, intellectual disability and even abortion of fetus. Phenytoin (PHT) is an antiepileptic drug which regulates ion influx especially Ca2+ and Na+ and widely prescribed to pregnant women suffer from epilepsy. This study aimed to investigate neurodevelopmental features of primary culture of hippocampal cells such as morphology, dendritogenesis, cytotoxicity and cell death in the presence and absence of PHT.
Methods
Primary culture of hippocampal neurons from neonatal rat was treated by 25 and 50 μg/ml of PHT and morphological development was evaluated during the 14 days. Arborization of neurons during the time was monitored by light microscopy. MTT assay and lactate dehydrogenase (LDH) penetrating test also assessed PHT imposed cytotoxicity.
Results
Our results confirmed high dose of PHT could cause excessive cell death in neural cells. PHT exposing causes morphological abnormalities in hippocampal neurons such as shrieked cell body or thick and short dendrite. PHT also prevents branching of dendrites and induces LDH leakage that refers to cytotoxicity.
Discussion
By considering the Ca2+ and Na+ important roles in cell development process, PHT affect neural shape and arborization rate. It could retard neural development and lead neurons to the cell death. PHT is an anticonvulsant that prescribed to pregnant women so could disrupt brain development and increase the risk of mental retardation in newborn children.
{"title":"Neurotoxic effects of phenytoin on primary culture of hippocampal neurons: Neural development retardation","authors":"Arezu Marefat, Leila Sadeghi","doi":"10.1016/j.npbr.2020.03.001","DOIUrl":"10.1016/j.npbr.2020.03.001","url":null,"abstract":"<div><h3>Objectives</h3><p>Ions are key regulators of the morphogenesis, dendritogenesis and development of neurons therefore drugs that perturb ion homeostasis are associated with high risk of mental retardation, intellectual disability and even abortion of fetus. Phenytoin (PHT) is an antiepileptic drug which regulates ion influx especially Ca<sup>2+</sup> and Na<sup>+</sup> and widely prescribed to pregnant women suffer from epilepsy. This study aimed to investigate neurodevelopmental features of primary culture of hippocampal cells such as morphology, dendritogenesis, cytotoxicity and cell death in the presence and absence of PHT.</p></div><div><h3>Methods</h3><p>Primary culture of hippocampal neurons from neonatal rat was treated by 25 and 50 μg/ml of PHT and morphological development was evaluated during the 14 days. Arborization of neurons during the time was monitored by light microscopy. MTT assay and lactate dehydrogenase (LDH) penetrating test also assessed PHT imposed cytotoxicity.</p></div><div><h3>Results</h3><p>Our results confirmed high dose of PHT could cause excessive cell death in neural cells. PHT exposing causes morphological abnormalities in hippocampal neurons such as shrieked cell body or thick and short dendrite. PHT also prevents branching of dendrites and induces LDH leakage that refers to cytotoxicity.</p></div><div><h3>Discussion</h3><p>By considering the Ca<sup>2+</sup> and Na<sup>+</sup> important roles in cell development process, PHT affect neural shape and arborization rate. It could retard neural development and lead neurons to the cell death. PHT is an anticonvulsant that prescribed to pregnant women so could disrupt brain development and increase the risk of mental retardation in newborn children.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 52-56"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90428202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-04-25DOI: 10.1016/j.npbr.2020.04.002
Laura Angioletti , Salvatore Campanella , Michela Balconi
Introduction
Impaired metacognition and impulsivity are critical factors in pathological gambling behavior subsistence. This study aims at jointly exploring metacognitive skills and impulsivity levels in subgroups of Parkinson’s Disease (PD) patients with different gambling status.
Method
48 PD participants were divided into three subgroups: PD Gamblers (PDG), PD patients with a previous history of gambling and PD controls. Impulsivity was assessed by the Barratt Impulsiveness Scale. After performing the Iowa Gambling Task (IGT), patients filled in a self-report measure to assess their metacognitive strategies.
Results
Findings highlighted that PDG showed higher levels of impulsivity than PD controls as reflected by clinical scales and behavioral measure. Also, PDG displayed a worse performance at IGT although they stated to use an efficacious strategy, suggesting then an erroneous metacognitive representation.
Conclusions
Overall findings proposed that high levels of impulsivity combined with an explicit metacognitive bias on self-efficacy could intervene in the persistence of pathological gambling behavior in PD patients.
{"title":"Metacognition deficits and impulsivity in Parkinson’s Disease patients with and without gambling behavior: A pilot study","authors":"Laura Angioletti , Salvatore Campanella , Michela Balconi","doi":"10.1016/j.npbr.2020.04.002","DOIUrl":"10.1016/j.npbr.2020.04.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Impaired metacognition and impulsivity are critical factors in pathological gambling behavior subsistence. This study aims at jointly exploring metacognitive skills and impulsivity levels in subgroups of Parkinson’s Disease (PD) patients with different gambling status.</p></div><div><h3>Method</h3><p>48 PD participants were divided into three subgroups: PD Gamblers (PDG), PD patients with a previous history of gambling and PD controls. Impulsivity was assessed by the Barratt Impulsiveness Scale. After performing the Iowa Gambling Task (IGT), patients filled in a self-report measure to assess their metacognitive strategies.</p></div><div><h3>Results</h3><p>Findings highlighted that PDG showed higher levels of impulsivity than PD controls as reflected by clinical scales and behavioral measure. Also, PDG displayed a worse performance at IGT although they stated to use an efficacious strategy, suggesting then an erroneous metacognitive representation.</p></div><div><h3>Conclusions</h3><p>Overall findings proposed that high levels of impulsivity combined with an explicit metacognitive bias on self-efficacy could intervene in the persistence of pathological gambling behavior in PD patients.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 88-95"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73459560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-06-01Epub Date: 2020-02-21DOI: 10.1016/j.npbr.2020.02.002
Wendy Marie Ingram , Anna M. Baker , Christopher R. Bauer , Jason P. Brown , Fernando S. Goes , Sharon Larson , Peter P. Zandi
Background
Major Depressive Disorder (MDD) is one of the most common mental illnesses and a leading cause of disability worldwide. Electronic Health Records (EHR) allow researchers to conduct unprecedented large-scale observational studies investigating MDD, its disease development and its interaction with other health outcomes. While there exist methods to classify patients as clear cases or controls, given specific data requirements, there are presently no simple, generalizable, and validated methods to classify an entire patient population into varying groups of depression likelihood and severity.
Methods
We have tested a simple, pragmatic electronic phenotype algorithm that classifies patients into one of five mutually exclusive, ordinal groups, varying in depression phenotype. Using data from an integrated health system on 278,026 patients from a 10-year study period we have tested the convergent validity of these constructs using measures of external validation, including patterns of psychiatric prescriptions, symptom severity, indicators of suicidality, comorbidity, mortality, health care utilization, and polygenic risk scores for MDD.
Results
We found consistent patterns of increasing morbidity and/or adverse outcomes across the five groups, providing evidence for convergent validity.
Limitations
The study population is from a single rural integrated health system which is predominantly white, possibly limiting its generalizability.
Conclusion
Our study provides initial evidence that a simple algorithm, generalizable to most EHR data sets, provides categories with meaningful face and convergent validity that can be used for stratification of an entire patient population.
{"title":"Defining major depressive disorder cohorts using the EHR: Multiple phenotypes based on ICD-9 codes and medication orders","authors":"Wendy Marie Ingram , Anna M. Baker , Christopher R. Bauer , Jason P. Brown , Fernando S. Goes , Sharon Larson , Peter P. Zandi","doi":"10.1016/j.npbr.2020.02.002","DOIUrl":"10.1016/j.npbr.2020.02.002","url":null,"abstract":"<div><h3>Background</h3><p>Major Depressive Disorder<span> (MDD) is one of the most common mental illnesses and a leading cause of disability worldwide. Electronic Health Records (EHR) allow researchers to conduct unprecedented large-scale observational studies investigating MDD, its disease development and its interaction with other health outcomes. While there exist methods to classify patients as clear cases or controls, given specific data requirements, there are presently no simple, generalizable, and validated methods to classify an entire patient population into varying groups of depression likelihood and severity.</span></p></div><div><h3>Methods</h3><p>We have tested a simple, pragmatic electronic phenotype algorithm that classifies patients into one of five mutually exclusive, ordinal groups, varying in depression phenotype. Using data from an integrated health system<span> on 278,026 patients from a 10-year study period we have tested the convergent validity of these constructs using measures of external validation, including patterns of psychiatric prescriptions, symptom severity, indicators of suicidality, comorbidity, mortality, health care utilization, and polygenic risk scores for MDD.</span></p></div><div><h3>Results</h3><p>We found consistent patterns of increasing morbidity and/or adverse outcomes across the five groups, providing evidence for convergent validity.</p></div><div><h3>Limitations</h3><p>The study population is from a single rural integrated health system which is predominantly white, possibly limiting its generalizability.</p></div><div><h3>Conclusion</h3><p>Our study provides initial evidence that a simple algorithm, generalizable to most EHR data sets, provides categories with meaningful face and convergent validity that can be used for stratification of an entire patient population.</p></div>","PeriodicalId":49756,"journal":{"name":"Neurology Psychiatry and Brain Research","volume":"36 ","pages":"Pages 18-26"},"PeriodicalIF":0.0,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.npbr.2020.02.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37777444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}